Cargando…

Vaccines for the prevention of cervical cancer /

Cervical cancer is the second most common form of cancer found in women and it is responsible for more than a quarter of a million deaths worldwide each year. With approximately 70% of cervical cancers now known to be caused by two types of the human papilloma virus (HPV), there is great interest su...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Stern, Peter L., Kitchener, Henry C.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Oxford : Oxford University Press, 2008.
Colección:Oxford oncology library.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBSCO_ocn801405323
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu---unuuu
008 120723s2008 enka ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d E7B  |d OCLCQ  |d OCLCF  |d OCLCE  |d OCLCO  |d OCLCQ  |d NLGGC  |d YDXCP  |d EBLCP  |d IDEBK  |d OCLCO  |d OCLCQ  |d OCLCO  |d CUV  |d OCLCQ  |d D6H  |d AZK  |d OCLCO  |d STBDS  |d AGLDB  |d MOR  |d CCO  |d PIFAG  |d ZCU  |d OCLCQ  |d MERUC  |d OCLCQ  |d OCLCA  |d U3W  |d STF  |d WRM  |d MNI  |d OCLCQ  |d VTS  |d COCUF  |d NRAMU  |d ICG  |d VT2  |d TOF  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d REC  |d OCLCO  |d DKC  |d OCLCQ  |d AU@  |d UX1  |d HS0  |d UWK  |d ADU  |d LIP  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d UKCRE  |d UKAHL  |d AJS  |d OCLCQ  |d OCLCO  |d CNNOR  |d OCLCQ  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO 
019 |a 746111982  |a 801363650  |a 961561849  |a 962671706  |a 967256199  |a 978442746  |a 978881837  |a 988459349  |a 990386314  |a 991921722  |a 1016985278  |a 1017995275  |a 1037792930  |a 1038042607  |a 1038665031  |a 1042931759  |a 1043665353  |a 1045520884  |a 1047949306  |a 1055403779  |a 1065080093  |a 1066432357  |a 1080526598  |a 1081249175  |a 1097144810  |a 1109068172  |a 1110411530  |a 1113452472  |a 1119030572  |a 1119041905  |a 1120932191  |a 1121018135  |a 1135590072  |a 1153501120  |a 1157902308  |a 1178723598  |a 1183976587  |a 1228554783  |a 1249170993 
020 |a 9780191575457  |q (electronic bk.) 
020 |a 0191575453  |q (electronic bk.) 
020 |a 9780191740060 
020 |a 0191740063 
020 |a 0199607184 
020 |a 9780199607181 
020 |a 1283581264 
020 |a 9781283581264 
020 |a 9786613893710 
020 |a 6613893714 
020 |z 9780199543458 
020 |z 0199543453 
029 1 |a AU@  |b 000051591738 
029 1 |a AU@  |b 000062595069 
029 1 |a DEBBG  |b BV040834240 
029 1 |a DEBBG  |b BV043168738 
029 1 |a DEBBG  |b BV044167213 
029 1 |a DEBSZ  |b 421395591 
029 1 |a NZ1  |b 14694020 
035 |a (OCoLC)801405323  |z (OCoLC)746111982  |z (OCoLC)801363650  |z (OCoLC)961561849  |z (OCoLC)962671706  |z (OCoLC)967256199  |z (OCoLC)978442746  |z (OCoLC)978881837  |z (OCoLC)988459349  |z (OCoLC)990386314  |z (OCoLC)991921722  |z (OCoLC)1016985278  |z (OCoLC)1017995275  |z (OCoLC)1037792930  |z (OCoLC)1038042607  |z (OCoLC)1038665031  |z (OCoLC)1042931759  |z (OCoLC)1043665353  |z (OCoLC)1045520884  |z (OCoLC)1047949306  |z (OCoLC)1055403779  |z (OCoLC)1065080093  |z (OCoLC)1066432357  |z (OCoLC)1080526598  |z (OCoLC)1081249175  |z (OCoLC)1097144810  |z (OCoLC)1109068172  |z (OCoLC)1110411530  |z (OCoLC)1113452472  |z (OCoLC)1119030572  |z (OCoLC)1119041905  |z (OCoLC)1120932191  |z (OCoLC)1121018135  |z (OCoLC)1135590072  |z (OCoLC)1153501120  |z (OCoLC)1157902308  |z (OCoLC)1178723598  |z (OCoLC)1183976587  |z (OCoLC)1228554783  |z (OCoLC)1249170993 
037 |n Title subscribed to via ProQuest Academic Complete 
042 |a dlr 
050 4 |a RC280.U8  |b V33 2008eb 
060 4 |a QZ 266 V116 2008 
072 7 |a HEA  |x 039030  |2 bisacsh 
072 7 |a MED  |x 062000  |2 bisacsh 
082 0 4 |a 616.99/466  |2 22 
084 |a 44.92  |2 bcl 
049 |a UAMI 
245 0 0 |a Vaccines for the prevention of cervical cancer /  |c edited by Peter L. Stern and Henry C. Kitchener. 
260 |a Oxford :  |b Oxford University Press,  |c 2008. 
300 |a 1 online resource (xix, 149 pages) :  |b color illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
490 1 |a Oxford oncology library 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
506 |3 Use copy  |f Restrictions unspecified  |2 star  |5 MiAaHDL 
533 |a Electronic reproduction.  |b [Place of publication not identified] :  |c HathiTrust Digital Library,  |d 2011.  |5 MiAaHDL 
538 |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.  |u http://purl.oclc.org/DLF/benchrepro0212  |5 MiAaHDL 
583 1 |a digitized  |c 2011  |h HathiTrust Digital Library  |l committed to preserve  |2 pda  |5 MiAaHDL 
505 0 |a Preface; Contributors; Abbreviations; Glossary; Part 1-Prevention and current treatment; 1 The UK cervical screening programme; 2 Management of cervical intraepithelial neoplasia (CIN); Part 2-HPV and disease; 3 Role of HPV in cervical carcinogenesis; 4 HPV and genital cancer: the essential epidemiology; 5 The role of HPV testing in cervical screening; Part 3-Immune control of HPV infection in cervical neoplasia; 6 Natural immune control of HPV infection; 7 Prophylactic HPV vaccines: pre-clinical and proof of principle studies; 8 Prophylactic HPV vaccination: current status. 
505 8 |a 9 Introduction of HPV prophylactic vaccinationPart 4-Challenges and future developments; 10 HPV vaccination in the developing world; 11 Screening post vaccination; 12 Second-generation HPV prophylactic vaccines; 13 Therapeutic HPV vaccines; 14 Conclusion; Index; A; B; C; D; E; F; G; H; I; K; L; M; N; O; P; Q; R; S; T; U; V; W; Y. 
520 |a Cervical cancer is the second most common form of cancer found in women and it is responsible for more than a quarter of a million deaths worldwide each year. With approximately 70% of cervical cancers now known to be caused by two types of the human papilloma virus (HPV), there is great interest surrounding the approval of the first preventative vaccines for clinical use. Despite this excitement, many questions remain about how the new vaccines should best be implemented and howcervical cancer screening will change following vaccination. Part of the Oxford Oncology Library series, this practic. 
546 |a English. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Cervix uteri  |x Cancer  |x Prevention. 
650 0 |a Cancer vaccines. 
650 0 |a Papillomavirus vaccines. 
650 2 |a Uterine Cervical Neoplasms  |x prevention & control 
650 2 |a Papillomavirus Vaccines 
650 2 |a Cancer Vaccines 
650 6 |a Vaccins anticancéreux. 
650 6 |a Vaccins antipapillomavirus. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a Papillomavirus vaccines  |2 fast 
650 7 |a Cancer vaccines  |2 fast 
650 7 |a Cervix uteri  |x Cancer  |x Prevention  |2 fast 
650 1 7 |a Baarmoederhalskanker.  |2 gtt 
650 1 7 |a Vaccins.  |2 gtt 
650 1 7 |a Humaan papillomavirus.  |2 gtt 
700 1 |a Stern, Peter L. 
700 1 |a Kitchener, Henry C. 
776 0 8 |i Print version:  |t Vaccines for the prevention of cervical cancer.  |d Oxford : Oxford University Press, 2008  |z 9780199543458  |w (DLC) 2009417494  |w (OCoLC)271769205 
830 0 |a Oxford oncology library. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=467512  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH37530487 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL975600 
938 |a ebrary  |b EBRY  |n ebr10581627 
938 |a EBSCOhost  |b EBSC  |n 467512 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 389371 
938 |a Oxford University Press USA  |b OUPR  |n EDZ0000091507 
938 |a YBP Library Services  |b YANK  |n 9316050 
938 |a YBP Library Services  |b YANK  |n 12890080 
994 |a 92  |b IZTAP